Skip to main content

Lifestyle counselling as secondary prevention in patients with minor stroke or transient ischemic attack: a randomized controlled pilot study

Abstract

Background

Patients with minor stroke or transient ischemic attacks have an increased risk of future strokes. These patients are often discharged home with limited specialized follow-up, although close to half of them experience cognitive deficits. Simple encouragements to avoid smoking, be physically active, and to take preventive medication are often insufficient to ensure adherence and more comprehensive interventions are needed to support the patients in adapting healthy behaviour. The aim of this study was to test the feasibility and potential effect of an early initiated, patient-centred intervention to patients with minor stroke or transient ischemic attacks targeting smoking, physical activity, and medication adherence, in a randomized, controlled pilot trial.

Methods

Hospitalized patients were randomized to usual care or an intervention consisting of health behavioural counselling based on the 5A’s model, telephone follow-up (4 and 8 weeks), and monitoring of physical activity. Follow-up time was 12 weeks. Feasibility was on the following domains: eligibility, acceptance, demand and practicality, adherence, attrition, and implementation and integration.

Results

Forty patients of 84 potentially eligible were randomized to the two treatment arms (20 intervention/20 usual care). Thirty-two completed the 12-week follow-up, while 8 were either excluded or lost to follow-up. With few changes, the intervention was feasible and possible to deliver according to the protocol.

Conclusion

It was possible to identify relevant patients who could potentially benefit from a behavioural intervention, recruit and randomize them early after admission and retain most participants in the study until follow-up and derive statistical estimates to guide the design of large-scale randomized controlled trials.

Trial registration

ClinicalTrials.gov Identifier: NCT03648957. Registered 28 August 2018.

Peer Review reports

Key messages regarding feasibility

  • We examined the feasibility of patient-centred counselling focusing on smoking cessation, physical activity, and adherence to preventive medication in a fast-track care pathway for patients with minor stroke or transient ischemic attacks who were discharged home.

  • The structured theory-based counselling approach proved to be feasible in the early diagnostic stages and within a hospital-based environment; however, inclusion of patients and provision of the intervention within the short time frame of the fast-track care pathway were found to be challenging, and some elements of the protocol had to be omitted. The use of activity trackers to encourage physical activity required more training and support than anticipated.

  • The counselling programme will be feasible to administer in a sufficiently powered trial; however, the screening and inclusion process will have to be optimized.

Background

The rate of recurrent strokes is high among stroke survivors with approximately 12% of all stroke victims experiencing a new stroke within the first year and one in four patients admitted with a stroke having previously had a stroke or transient ischemic attack (TIA) [1]. Potentially modifiable risk factors, including hypertension, smoking, physical inactivity, abdominal obesity, and unhealthy diet, all contribute to the risk of stroke [2, 3]. Preventive medication, such as antithrombotics, antihypertensives, and statins, is also important in the prevention of recurrent stroke [4], although evidence suggests that adherence to preventive medication among stroke survivors decrease with time [5,6,7,8].

Behavioural interventions have previously demonstrated a beneficial effect on hypertension and blood lipids and can potentially be used as part of the secondary prevention, but we lack knowledge as to which approaches are preferable or most efficient in preventing new strokes, beyond the beneficial effect of physical exercise on hypertension [9]. The 5A’s model [10, 11] and Motivational Interviewing [12] are commonly used models for health counselling which have both been validated for use in comparable patient populations. The 5A’s model is a structured approach for facilitating the patient’s personal reflection and goal setting. Motivational interviewing use a person-centred approach which emphasizes acceptance and focus on the needs of the patient and the patient’s life situation as key elements of health counselling.

Most patients with stroke experience minor or transient neurological deficits and are discharged home without significant disabilities. Yet, close to half of patients with minor stroke or TIA report having subtle cognitive and communicative problems, predominantly problems with memory, fatigue, reading, and participating in conversations 3 months after discharge [13]. These impairments along with other factors might influence the stroke survivors ability to manage their own health [14]. We therefore need more research on how behavioural interventions can support the patients’ needs related to improving self-management strategies in secondary and tertiary prevention following stroke.

The aims of this study were to evaluate the feasibility of a patient-centred counselling intervention focused on smoking cessation, physical activity, and adherence to preventive medication in transitional care of patients with minor stroke or TIA and the feasibility of potential outcome measures.

Methods

We conducted a parallel group randomized controlled pilot and feasibility trial to test the feasibility of implementing an individual face-to-face health behavioural counselling with post-discharge follow-up sessions against usual care in a fast-track stroke care setting. A protocol article outlining the study design and procedures has previously been published [15].

Setting and participants

The target population was patients hospitalized with recent minor stroke or TIA who were discharged home. We included patients admitted to the Department of Neurology at Nordsjællands Hospital, Denmark, from October 2018 to January 2020, with minor stroke (ICD-10 I61, I63, I64; Scandinavian Stroke Scale 45–58) or TIA (ICD-10 G45.9) within the previous 7 days. In Denmark, all patients suspected of acute stroke or TIA undergo admission through a standardized fast-track patient pathway. This pathway includes rapid diagnostic procedures, treatment, and evaluation of risk factors for recurrent strokes. Typically, patients are hospitalized for 3 days. Patients were eligible if they were ≥ 18 years old, could consent to participation, and were discharged home. Exclusion criteria were severe communication barriers, inability to use a telephone, severe disability prior to the stroke (WHO performance status > 2; incapable of self-care and mobilized less than 50% of the day), active abuse of alcohol or narcotics, severe psychiatric illness (affective disease, dementia, schizophrenia), or inability to participate due to severe medical frailty. All new patients with suspected stroke or TIA were screened for eligibility by the primary researcher (J. L.). Potential participants were invited through verbal and written information before discharge. All participants gave written informed consent before participation.

A sample size of 40 randomized participants was chosen weighing the precision of the feasibility measures against the available resources. With this sample size, a theoretical attrition rate of 10% could be estimated with a precision of 3–24% (95% confidence) and a theoretical adherence rate of 5% with a precision of 1–17% (95% confidence) using the Exact method [16].

Procedures

Baseline assessment

Demographic and health behavioural information was collected using standardized questions from the Danish National Health Survey [17], in addition with assessment of stroke severity [18, 19], prior health problems [20], vital signs [21], spirometry (FEV1/FVC) [22], and biochemistry (HbA1c and blood lipids) [4].

Randomization and group allocation

Participants were allocated to either intervention or usual care after baseline testing using a simple non-stratified 1:1 randomization. A computer-generated (using the rbinom-function in R [23]) randomization sequence was implemented into the Research Electronic Data Capture (RedCap) software [24], which secures concealment of future allocations and prohibits post hoc changes to the allocation. The participants remained in the allocation group for the entire study period.

Intervention

In brief, participants randomized to the intervention arm received nurse-led targeted health behaviour counselling focusing on smoking cessation, physical activity, and adherence to preventive medication, in addition to usual care. When possible, we tested the participants aerobic capacity prior to the initial counselling using the Astrand-Rhyming cycle test [25]. The initial counselling session was provided face to face by the primary investigator before discharge from the hospital. The counselling employed a patient-centred approach [12] and was structured around the 5A’s model [10, 11] (Fig. 1) with the intention of engaging the participant in healthy behaviour and adhering to preventive medication to reduce their risk of recurrent cerebrovascular events. Participants in the intervention arm were issued a VivoFit activity tracker to count daily steps and aerobic walking time.

Fig. 1
figure 1

The 5A’s approach modified from Vallis et al. (2013) [10] and Sherson et al. (2014) [11], as proposed in Liljehult et al. (2020) [15]

Post-discharge counselling was provided by J. L. via telephone 4 and 8 weeks after discharge and aimed at maintaining motivation and adjusting goals and strategies if necessary. A standardized question guide was used to ensure the consistency of the telephone counselling with questions on overall well-being, persistence of symptoms or functional deficits, adherence to medication, side effects, physical activity, smoking, and use of health care services. The intervention is described in details in the published protocol [15].

Usual care

Participants in the control arm received standard care, which included a review of prescribed medication, and verbal and written encouragement to cease use of tobacco, diminish the intake of alcohol, be physically active to the extent possible, and eat a healthy diet (reduce the consumption of red meat and salt and increase the consumption of fish, fruit, and vegetables) [26].

Outcome measures

The primary outcomes were measures of feasibility: (1) eligibility including the eligibility rate (proportion of eligible patients compared to the total number of stroke patients), (2) acceptance including the study participation rate (proportion of patients accepting participation in the study), (3) demand and practicality (proportion of study elements that could be delivered according to the protocol), (4) adherence including the degree of adherence to the programme (proportion of attendance in follow-up sessions), (5) attrition (drop-out and drawn-out), and (6) implementation and integration evaluation the ability of delivering the intervention per protocol.

Secondly, we tested the feasibility of potential clinical outcome measures for use in future studies including the following: arterial blood pressure measured in accordance with US guidelines [27]; self-reported smoking, physical activity level (International Physical Activity Questionnaire-Short Form [28, 29]); adherence to medication (number of missed/consumed doses in the past 7 days); anthropometrics (body weight, waist/hip ratio); fatigue (Fatigue Assessment Scale [30]); long-term readmission with stroke, TIA, or ischemic heart disease; and fatality within 1 year.

Follow-up

Participants from both allocation groups were reassessed by the primary investigator (J. L.) in a hospital-based outpatient clinic 12 weeks after discharge. To evaluate the feasibility of potential outcome measures, we measured the following: arterial blood pressure, body weight, and waist/hip ratio, fatigue, smoking, physical activity, and adherence to prescribed medication at 12 weeks. Information on 1-year mortality and stroke recurrence was obtained from electronic hospital records.

Analysis

We used the model for designing feasibility studies in preventive medicine proposed by Bowen et al. [31] to evaluate the feasibility. The eligibility rate was calculated as the proportion of all screened patients who met the eligibility criteria and were available for invitation. The acceptance rate was calculated as the proportion of invited patients who accepted participation, in contrast to patients who declined participation or cases where the invitation to participate was retracted before inclusion. Practicality was calculated as follows: (1) the proportion of included participants who completed the baseline measurements (baseline interview, SSS, spirometry) or (2) the proportion of participants allocated to the intervention arm who completed the initial elements of the intervention (VivoFit, face-to-face counselling, Astrand-Rhyming cycling test). The adherence and attrition rates were calculated as follows: (1) the proportion of participants in the intervention arm who participated in the follow-up telephone counselling (4 and 8 weeks after discharge) and used the VivoFit, in contrast to participants who were either drawn out or unavailable/non-adherent, and (2) the proportion of all participants who completed the 12-week follow-up and were included in the 1-year follow-up, in contrast to participants who were either drawn out or lost to follow-up. The implementation rate was calculated as the proportion of participants in the intervention arm who completed all elements of the original protocol or a modified version (omitting the Astrand-Rhyming cycling test) in contrast to participants who were non-adherent with one or more elements and the proportion of the participants in the control arm who completed the control protocol in contrast to participants who did not complete the 12 week follow-up. Specific progression criteria were not specified a priori — but the progression of the study was monitored through regular meetings with the programme steering committee at which data on recruitment, protocol adherence, and follow-up were reported and discussed in plenum. Confidence intervals of all proportions were calculated using the Exact method (Clopper-Pearson).

Data was collected in real time using RedCap electronic case report forms. Statistical analyses were carried out in R 3.3.1/R Studio 0.99.

Ethical considerations

The study was conducted in accordance with the Helsinki Declaration [32] including respect for the participants’ autonomy and right to informed consent. The participants were informed that participation was voluntary, and that further participation could be declined at any time without explanation.

The study protocol was approved by the Scientific Committee of the Capital Region (H-17040484) and the Danish Data Protection Agency (j.nr. VD-2018–306, I-6552). The study protocol was registered at ClinicalTrials.gov (NCT03648957).

Results

Forty patients accepted participation and were randomly assigned to the two treatments arms (20 intervention and 20 usual care, Table 1 presents the study population characteristics). The median follow-up time was 85 days (range 82–104 days).

Table 1 Baseline study population characteristics

Feasibility

Eligibility and acceptance

A total of 1010 patients hospitalized in the acute stroke ward were screened for eligibility, of whom 84 were invited to participate in the study. Common reasons for non-eligibility can be seen in Fig. 2. Forty patients accepted participation, while 8 were excluded before inclusion and 36 declined participation. Exclusion after invitation to participate was due to the patient being discharged before consent was obtained (n = 4), the stroke diagnosis being refuted (n = 2), or changes in the patients’ condition (new stroke or delirium). Reported reasons for declining participation included the following: not finding the intervention to be relevant (perceiving their lifestyle to be healthy already (n = 5); not finding their stroke to be associated with their behaviour [n = 4]), already having regular contact with health professionals (n = 2), time constrains due to work/family obligations (n = 5), not having sufficient energy to participate in anything beyond the standard treatment (n = 15), while five patients did not specify a reason. Twenty-eight patients were unavailable for invitation due to practical clinical (see Fig. 2).

Fig. 2
figure 2

Patient flow from screening to final follow-up

Demand and practicality

In general, the baseline procedures (SSS, spirometry, and face-to-face counselling) were carried out in high accordance with the protocol (> 95%) (Fig. 3). Setting up the activity tracking devices (VivoFit 4.0) proved to be more time-consuming than expected. All participants needed assistance with installing the smartphone application, setting up a user profile, connecting the device, or support with transferring data to the application after discharged.

Fig. 3
figure 3

Evaluation of the feasibility

In just seven intervention cases (35%) were we able to perform the Astrand-Rhyming cycle test at baseline due to time constrains, and most participants did not find it relevant in relation to the counselling. In addition, two participants declined performing the test due to knee pain.

Adherence

In the intervention group, we were able to contact 15 participants after 4 weeks and 12 after 8 weeks for telephone follow-up (Figs. 2 and 3). We received activity tracker data from 12 participants of the intervention group (60%). Two participants wanted to use their own devices (no data returned), one was drawn out before the activity tracker was issued, and five never transferred any data. Among the participants who transferred data, the activity tracker was worn in 90.0% of the days (959 applicable measurements per 1066 follow-up days, 95% CI 88.0–91.7) of the intervention period with 4 participants wearing it all days (range 62–100%; see Additional files 2 and 3). Evaluation of the activity tracker data showed a substantial variation in steps per day and aerobic steps per day both within and between subjects. In four participants, the data showed a clear central tendency, while the rest had several clusters throughout their range of activity which might resemble multiple concurrent patterns in the individual activity.

Attrition

Thirty-two patients completed the 12-week follow-up period, resulting in an attrition rate at 20% (5 intervention/3 usual care group). Four participants were drawn out after randomization: One was discharged before the intervention had been provided, three had a change of diagnosis after magnetic resonance imaging, and 4 were lost to follow-up. Two follow-up sessions had to be conducted via telephone due to COVID-19 pandemic restrictions at the hospital, and in these, we used blood pressure measurements performed by the patient or the general practitioner.

Implementation and integration

We intended to recruit all participants before discharge and integrate the intervention pragmatically within the existing standard treatment. In general, the protocol was manageable within the clinical setting, although we did identify some challenges. In 84 cases, the initial medical records lacked sufficient information to evaluate the eligibility of the patients, and acquiring the information proved to be time-consuming. All participants were discharged home without the intervention causing delay of care.

Content and feasibility of the counselling

Nineteen intervention participants (95%) received face-to-face counselling, while 15 (75%) and 12 (60%) received subsequent telephone counselling after 4 and 8 weeks, respectively. Medication adherence was discussed with all participants. Two participants had not taken any medication before, and nine had changes to their medication which urged them to change previous habits, while four had no changes to their medication. Four reported being ambivalent towards taking medication. Eighteen participants (90%) received counselling in increasing the level of physical activity. Walking was the preferred type of activity (n = 12), while other types included biking, yoga, fitness, and running. Three participants (15%) were current smokers and were recommended to stop smoking: one was already following a cessation course, while the last two intended to stop smoking. Three participants asked for dietary recommendations, which was supplied at their discretion, although this was not part of the protocol.

The 5A’s model organizes the counselling session into a sequence of distinct phases. The model provided rigorous structure to the sessions and guided the direction of the conversation. Each of the distinct phases have a specific function in the session and gives varying emphasis to the contribution of the patient and the health professional. This helped the counselling become a two-way conversation with balanced contributions from the patient and the health professional. Most participants found it difficult to set specific and measurable goals.

Feasibility of the outcome measures

Measurement of the potential outcome measures was possible according to the study protocol for all participants who came to the outpatient clinic after 12 weeks (estimates per allocation group at baseline and follow-up are available in Additional file 1).

Arterial blood pressure and body composition measures (weight, body mass index, and waist-to-hip ratio) were easily obtained without discomfort or nuisance for the participants. We did encounter some challenges with obtaining the patient-reported outcome measures — mainly that the participants found it hard to recall their level of physical activity and if they had missed any doses of medicine within the last week. Some participants reported using less time on physical activity, although they found it hard to assess if the intensity of activities had changed. The fatigue score was applicable but did require some facilitation from the researcher. Overall, the participants reported feeling more fatigued with the most noticeable difference in the item “Mentally, I feel exhausted”. Potential readmissions and fatalities could be tracked through the electronic patient registry, although only two readmissions were observed.

Discussion

This study found that it was possible to identify relevant patients early after hospital admission, to randomize participants, and to retain them in the study until follow-up. Few, yet appreciable, changes had to be made to the study protocol, but the overall setup and the structured theory-based counselling approach proved to be feasible in the early diagnostic stages and within a hospital-based environment.

The overall goal of the intervention was to support patients in caring for their own health following a minor stroke or TIA. This included providing knowledge about the disease and behavioural risk factors, the ability to set realistic goals and identify strategies for obtaining these goals, the ability to find relevant help and support, and support of confidence through encouragement and recognition.

The early recruitment of participants allowed for a large part of the target population to be identified. Implementing this in a fast-track patient pathway, however, resulted in potentially relevant patients being unavailable for recruitment and participants being excluded due to the stroke diagnosis being revoked. All patients admitted to the ward were assessed in order to capture as many eligible patients as possible and estimate the potential demand for the intervention. As a result, many non-eligible patients were screened and excluded. Even though stroke mimics were excluded from this study — some did present significant vascular risk factors, and in clinical practice, health behavioural counselling might in fact be beneficial.

The rationale behind including the cycle test and spirometry in addition to the counselling was to facilitate reflection on potential consequences of health behaviour and ensure the participants in the safety of being physically active after a stroke. However, the feedback from the participants indicated that these elements did not have the intended effect, with some participants even refusing to undergo the cycle test due to musculoskeletal conditions.

Previous research has proposed that using a well-structured approach for health behavioural counselling might be helpful to health professionals [33]. For the counselling in this intervention, we used the 5A’s model [15] to provide structure, in combination with techniques from Miller and Rollnick [12], which facilitated a more balanced dialogue between the patient and the health professional. The 5A’s model emphasizes that health recommendations should be specific and personal. This supports the finding of Reed et al. [34] that patients with stroke found it easier to acquire health information if it was connected to their current life situation. Health counselling might therefore be more efficient if it specifically targets problems relevant for the individual patient and is provided in a way that takes the patient’s life situation into account.

Providing effective health counselling requires the health professional to have relevant knowledge to give specific recommendations and make situated clinical decisions, which requires knowledge about the recipient and the context in which the behaviour is performed [35]. In this study, all counselling was provided by the primary investigator who had substantial clinical experience as a nurse in stroke care. This might have strengthened the quality of the counselling provided and have limited the amount of training required. It is uncertain how much training it would require if less experienced health professionals were to adapt the model.

Wearable activity trackers to monitor physical activity have become popular both in research and among common consumers, and evidence supports that they have a beneficial effect on physical activity in different populations [36,37,38]. We issued wearable activity trackers to participants in the intervention group to motivate the participants to physical activity. We met no noticeable resistance from the participants regarding using the device but identified several challenges. We had chosen a device with (1) long battery time so that the participants were not required to charge the device and (2) with a 4-week memory to limit the number of times the participants had to transfer data from the device to the smartphone application. The data transfer required an application to be downloaded and installed on a smartphone or tablet, the creation of a unique user account within the application, and the device to be connected to the application via Bluetooth. None of the participants was able to do this without support. When using technology as part of interventions provided to elderly and patients with neurological conditions, it is advisable to thoroughly consider possible limitations in terms of accessibility and technical skills of the participants and allocate resources to help and support.

Limitations

By design, the sample size of this study was limited as the main purpose was to test the feasibility. We assumed, a priori, that a sample size of 40 participants would be enough to test all procedures of the study protocol. Overall, this number of participants proved to be sufficient in terms of testing the procedures and estimating rates of inclusion and attrition. It also helped us gain valuable experience on how to integrate this type counselling into a relatively compressed patient pathway.

The study progression was not evaluated using predefined progression criteria but through regular discussions with the steering committee. This pragmatic approach was decided due to the multimodal nature of the intervention, which could have made it difficult to foresee which elements were relevant to evaluate. Previous research on comparable study populations and interventions had, furthermore, reported substantial variations in rates of eligibility, acceptability, and attrition, making it difficult to define realistic criteria.

A general limitation of behavioural counselling interventions, as well as this study, is the limited possibility of blinding, making a large-scale RCT prone to potential bias with influence from social desirability.

Only three (7.5%) participants were current smokers, as opposed to 23% of Danish stroke patients being registered as current smokers [39], implying that smokers might be underrepresented.

To reduce the risk of information bias, data were collected according to a standardized study manual, and self-reported data were collected at baseline and follow-up using the same methods in both treatment groups.

Implications for future research

In future research on health behaviour in patients with stroke, we need to address the prevalence of different health behaviours in more detail including the patients’ understanding of the causes of their stroke and awareness of risk, their readiness to change behaviour, and how patients who refuse to participate differ from participants, as alternative approaches might be needed to reach these patients.

Conclusion

The study showed that despite several implementation challenges, it is within a narrow time frame of initial care possible to identify, recruit and randomize relevant patients early after admission, and retain most participants in the study until follow-up. Adjustments had to be made to the study protocol during the pilot period including the general omittance of the Astrand-Rhyming cycle test. The study was not designed to formally test the effect of the intervention on blood pressure, though the findings may serve as basis for designing large-scale randomized controlled trials.

Availability of data and materials

Data used during the current study will be available from the corresponding author upon reasonable request.

References

  1. Olsen TS. Stroke recurrence and prognosis after stroke. Handb Clin Neurol. 2009;92:407-21. https://doi.org/10.1016/S0072-9752(08)01921-0. PMID: 18790287.

  2. Niewada M, Michel P. Lifestyle modification for stroke prevention: facts and fiction. Curr Opin Neurol. 2016;29:9–13.

    Article  CAS  PubMed  Google Scholar 

  3. O’Donnell MJ, Xavier D, Liu L, et al. Risk factors for ischaemic and intracerebral haemorrhagic stroke in 22 countries (the INTERSTROKE study): a case-control study. Lancet (London, England). 2010;376:112–23.

    Article  PubMed  Google Scholar 

  4. Kernan WN, Ovbiagele B, Black HR, et al. Guidelines for the prevention of stroke in patients with stroke and transient ischemic attack: a guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke. 2014;45:2160–236.

    Article  PubMed  Google Scholar 

  5. Glader E-L, Sjölander M, Eriksson M, et al. Persistent use of secondary preventive drugs declines rapidly during the first 2 years after stroke. Stroke. 2010;41:397–401.

    Article  PubMed  Google Scholar 

  6. Bushnell CD, Zimmer LO, Pan W, et al. Persistence with stroke prevention medications 3 months after hospitalization. Arch Neurol. 2010;67:1456–63.

    Article  PubMed  PubMed Central  Google Scholar 

  7. Cheiloudaki E, Alexopoulos EC. Adherence to treatment in stroke patients. Int J Environ Res Public Health. 16. Epub ahead of print 11 January 2019. https://doi.org/10.3390/ijerph16020196.

  8. Wong PS, Narasimhalu K, Tio SL, et al. Adherence to secondary stroke prevention medications in Singapore: a single center study. J Stroke Cerebrovasc Dis. 2024;33:107561.

    Article  PubMed  Google Scholar 

  9. Liljehult J, Christensen T, Molsted S, et al. Effect and efficacy of lifestyle interventions as secondary prevention. Acta Neurol Scand. Epub ahead of print 3 July 2020. https://doi.org/10.1111/ane.13308.

  10. Vallis M, Piccinini-Vallis H, Sharma AM, et al. Modified 5 as: minimal intervention for obesity counseling in primary care. Can Fam Physician. 2013;59:27–31.

    PubMed  PubMed Central  Google Scholar 

  11. Sherson EA, Yakes Jimenez E, Katalanos N. A review of the use of the 5 A’s model for weight loss counselling: differences between physician practice and patient demand. Fam Pract. 2014;31:389–98.

    Article  PubMed  Google Scholar 

  12. Miller WR, Rollnick S. Motivational Interviewing. 3rd ed. Book, New York: Guilford Publications; 2012.

    Google Scholar 

  13. Fens M, van Heugten CM, Beusmans GHMI, et al. Not as transient: patients with transient ischaemic attack or minor stroke experience cognitive and communication problems; an exploratory study. Eur J Gen Pract. 2013;19:11–6.

    Article  PubMed  Google Scholar 

  14. Liljehult J, Molsted S, Christensen T, et al. Mastering health following minor stroke-a qualitative explorative study. J Stroke Cerebrovasc Dis. 2022;31:106607.

    Article  PubMed  Google Scholar 

  15. Liljehult J, Molsted S, Møller T, et al. Lifestyle counselling as secondary prevention in patients with minor stroke and transient ischemic attack: study protocol for a randomized controlled pilot study. Pilot Feasibility Stud. 2020;6:40.

    Article  PubMed Central  Google Scholar 

  16. Hertzog MA. Considerations in determining sample size for pilot studies. Res Nurs Health. 2008;31:180–91.

    Article  PubMed  Google Scholar 

  17. Shields M, Shooshtari S. Determinants of self-perceived health. Heal Rep. 2001;13:35–52.

    CAS  Google Scholar 

  18. Lindenstrøm E, Boysen G, Waage Christiansen L, et al. Reliability of Scandinavian neurological stroke scale. Cerebrovasc Dis. 1991;1:103–7.

    Article  Google Scholar 

  19. Askim T, Bernhardt J, Churilov L, et al. The Scandinavian Stroke Scale is equally as good as the National Institutes of Health Stroke Scale in identifying 3-month outcome. J Rehabil Med. 2016;48:909–12.

    Article  PubMed  Google Scholar 

  20. Sundararajan V, Henderson T, Perry C, et al. New ICD-10 version of the Charlson comorbidity index predicted in-hospital mortality. J Clin Epidemiol. 2004;57:1288–94.

    Article  PubMed  Google Scholar 

  21. Liljehult J, Christensen T. Early warning score predicts acute mortality in stroke patients. Acta Neurol Scand. 2016;133:261–7.

    Article  CAS  PubMed  Google Scholar 

  22. Miller MR, Hankinson J, Brusasco V, et al. Standardisation of spirometry. Eur Respir J. 2005;26:319–38.

    Article  CAS  PubMed  Google Scholar 

  23. R-core@R-project.org. Binomial - the binomial distribution. stats v3.3. https://www.rdocumentation.org/packages/stats/versions/3.3/topics/Binomial. Accessed 18 Feb 2021.

  24. Vanderbilt. Research electronic data capture – about. 2017. https://projectredcap.org/about/. Accessed 9 Jul 2018.

  25. Lennon OC, Denis RS, Grace N, et al. Feasibility, criterion validity and retest reliability of exercise testing using the Astrand-Rhyming test protocol with an adaptive ergometer in stroke patients. Disabil Rehabil. 2012;34:1149–56.

    Article  PubMed  Google Scholar 

  26. Dansk Selskab for Apopleksi. Reference manual for the treatment of stroke and TIA [Referenceprogram for behandling a patienter med apopleksi og TCI 2013]. Copenhagen: Dansk Selskab for Apopleksi; 2013.

  27. Stergiou G, Palatini P, Asmar R, et al. Blood pressure measurement and hypertension diagnosis in the 2017 US guidelines. Hypertension. 2018;71:963–5.

    Article  CAS  PubMed  Google Scholar 

  28. Ekelund U, Sepp H, Brage S, et al. Criterion-related validity of the last 7-day, short form of the International physical activity questionnaire in Swedish adults. Public Health Nutr. 2006;9:258–65.

    Article  PubMed  Google Scholar 

  29. Bergman P, Grjibovski AM, Hagströmer M, et al. The association between health enhancing physical activity and neighbourhood environment among Swedish adults - a population-based cross-sectional study. Int J Behav Nutr Phys Act. 2009;6:8.

    Article  PubMed  PubMed Central  Google Scholar 

  30. De Vries J, Michielsen H, Van Heck GL, et al. Measuring fatigue in sarcoidosis: the Fatigue Assessment Scale (FAS). Br J Health Psychol. 2004;9:279–91.

    Article  PubMed  Google Scholar 

  31. Bowen DJ, Kreuter M, Spring B, et al. How we design feasibility studies. Am J Prev Med. 2009;36:452–7.

    Article  PubMed  PubMed Central  Google Scholar 

  32. World Medical Association. World Medical Association Declaration of Helsinki: ethical principles for medical research involving human subjects. JAMA. 2013;310:2191–4.

    Article  Google Scholar 

  33. Adamsen L, Andersen C, Lillelund C, et al. Rethinking exercise identity: a qualitative study of physically inactive cancer patients’ transforming process while undergoing chemotherapy. BMJ Open. 2017;7:e016689.

    Article  PubMed  PubMed Central  Google Scholar 

  34. Reed M, Harrington R, Duggan A, et al. Meeting stroke survivors’ perceived needs: a qualitative study of a community-based exercise and education scheme. Clin Rehabil. 2010;24:16–25.

    Article  PubMed  Google Scholar 

  35. Gillespie M. Using the situated clinical decision-making framework to guide analysis of nurses’ clinical decision-making. Nurse Educ Pract. 2010;10:333–40.

    Article  PubMed  Google Scholar 

  36. Laranjo L, Ding D, Heleno B, et al. Do smartphone applications and activity trackers increase physical activity in adults? Systematic review, meta-analysis and metaregression. Br J Sports Med. 2021;55(8):422–32. https://doi.org/10.1136/bjsports-2020-102892.

  37. Liu JYW, Kor PPK, Chan CPY, et al. The effectiveness of a wearable activity tracker (WAT)-based intervention to improve physical activity levels in sedentary older adults: a systematic review and meta-analysis. Arch Gerontol Geriatr. 2020;91:104211.

    Article  PubMed  Google Scholar 

  38. Chaudhry UAR, Wahlich C, Fortescue R, et al. The effects of step-count monitoring interventions on physical activity: systematic review and meta-analysis of community-based randomised controlled trials in adults. Int J Behav Nutr Phys Act. 2020;17:129.

    Article  PubMed  PubMed Central  Google Scholar 

  39. Danish Stroke Register. Danish stroke register -annual report 2018. Århus; 2019. https://www.sundhed.dk/content/cms/69/4669_dap_aarsrapport-2018_24062019final.pdf.

Download references

Acknowledgements

We wish to thank the Department of Neurology’s former head nurse Lene Hamberg, RN, MPO, for her collaboration in establishing the research programme. We also want to thank Professor Lis Adamsen, UCSF, Rigshospitalet, and professor Mary Jarden, Finsen Centeret, Rigshospitalet, for their help and guidance in designing and developing the study.

Project organization

The project was initiated as part of the CIRE neuro/psych research programme in collaboration between Nordsjællands Hospital, Hillerød, Copenhagen University College, and The University Hospitals Centre for Health Research UCSF, Copenhagen University Hospital (Rigshospitalet). The instigators of the CIRE neuro/psych research programme consist of researchers and managers from UCSF and Copenhagen University College, in collaboration with the UCSF Steering Committee consisting of representatives of the hospital managers in Region Hovedstaden. Progress of the project is presented to the members of the CIRE neuro/psych collaboration at biyearly meetings with representatives of all the involved parties. The UCSF Steering Committee has initiated the programme but has no direct involvement in the design or implementation of the individual studies.

Funding

Open access funding provided by Copenhagen University The pilot study has received funding from Nordsjællands Hospital, The University Hospital Centre for Health Research, Copenhagen University College, through the CIRE neuro/psych research programme, and extern funding from Anita & Tage Therkelsens Fond and TrygFonden (ID 126993). The CIRE neuro/psych collaboration has been involved in the design of the study protocol and is acting as overseers of the execution of the study.

Author information

Authors and Affiliations

Authors

Contributions

The protocol was designed by JL with contributions from all authors. The study was conducted with JL as the principal investigator in close collaboration with TC and with regular assessments by all authors. JL analysed the patient data, and all authors participated in interpretation of the data. All authors read and approved the final manuscript.

Corresponding author

Correspondence to Jacob Liljehult.

Ethics declarations

Ethics approval and consent to participate

Approved by the Danish Data Protection Agency (j.nr. VD-2018–306, I-6552). The protocol is in accordance with the rules of the Scientific Committee of the Capital Region, Denmark (H-17040484). The study protocol is registered at ClinicalTrials.gov (NCT03648957). Registered 28 August 2018, https://clinicaltrials.gov/ct2/show/record/NCT03648957.

Consent for publication

Not applicable.

Competing interests

The authors declare that they have no competing interests.

Additional information

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Supplementary Information

Additional file 1: Additional Table 1.

Measures of effect (Secondary and tertiary outcomes).

Additional file 2: Additional Table 2.

Activity tracker data presented per participant (3A) and per time interval (3B).

Additional file 3: Additional Figure.

Boxplots of steps per day for each participant sorted by median. Each measurement is represented by an opaque grey square and darker colouring therefore signifies clustering of measurements. The dashed lines indicate the quartiles of all measurements.

Rights and permissions

Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Liljehult, J., Molsted, S., Møller, T. et al. Lifestyle counselling as secondary prevention in patients with minor stroke or transient ischemic attack: a randomized controlled pilot study. Pilot Feasibility Stud 10, 50 (2024). https://doi.org/10.1186/s40814-024-01478-4

Download citation

  • Received:

  • Accepted:

  • Published:

  • DOI: https://doi.org/10.1186/s40814-024-01478-4

Keywords